Product Information
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $81.4303 per EA under NDC 00093356026. Its NADAC has been published 293 times since Nov 18, 2020.
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G
PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACIDManufacturer
Teva Pharmaceuticals USA Inc.NDC
00093356026
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090145On Market Since
8/31/2020
Price Statistics
The NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has been published 293 times since Nov 18, 2020, and over the history we have for it it has declined 7.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $81.4303 per EA |
|---|---|
| All-time high | $91.4380 (Jan 12, 2022) |
| All-time low | $52.1485 (Jul 17, 2024) |
| 52-week high | $81.4303 |
| 52-week low | $70.9860 |
| Median price | $77.8665 |
| Average price | $78.5562 |
| Largest weekly change | -33.1% (Jul 17, 2024) |
| Weeks tracked | 293 |
| Tracking since | Nov 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
The current National Average Drug Acquisition Cost (NADAC) for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G, manufactured by Teva Pharmaceuticals USA Inc., is $81.4303 per EA (NDC 00093356026), effective Jun 24, 2026.
How has the price of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G changed over time?
Over the history we have for it, the NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has declined 7.8%. It has been tracked across 293 weekly CMS publications since Nov 18, 2020.
What are the highest and lowest recorded NADAC prices for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
Since Nov 18, 2020, the NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has ranged from a low of $52.1485 (Jul 17, 2024) to a high of $91.4380 (Jan 12, 2022), with a median of $77.8665 per EA.
Are there cheaper alternatives to PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G, so no direct lower-cost alternative is listed.
Who manufactures PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G (NDC 00093356026) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification